Nusinersen Treatment in Adults With Spinal Muscular Atrophy
Tina Duong(Stanford University), Allan M. Glanzman(Boston Children's Hospital), Sally Dunaway Young(Palo Alto University), Jacinda B. Sampson(University of Alabama at Birmingham), Elizabeth Kichula(Children's Hospital of Philadelphia), Katharine A. Hagerman(Boston Children's Hospital), Zarazuela Zolkipli‐Cunningham(Children's Hospital of Philadelphia), Darryl C. De Vivo(Columbia University Irving Medical Center), Max Wintermark(University of Maryland, Baltimore), Connie Wolford(Boston Children's Hospital), Michael McDermott(Unknown), Chelsea E. Macpherson(Boston Children's Hospital), Basil T. Darras, Richard S. Finkel(St. Jude Children's Research Hospital), Amy Pasternak(Anna Needs Neuroblastoma Answers), Michael Zeineh(Stanford University), William B. Martens(MACOM (United States))
Cited by 77
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
|Stroke|2013|1.7k
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
|New England Journal of Medicine|2013|1.4k